LAST year’s KanaVape court case has prompted the European Union to re-think its stance in relation to two further cannabis-related matters.
A 12-page ‘non-paper’ released...
MEDICAL cannabis could be a boost to the North Macedonian economy, with NYSK and PharmaCann Polska – both subsidiaries of Warsaw-based PHCann International –...
CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns...
AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark for C$20m (£11.6m).
In addition, LGP...
PHARMACEUTICAL company Indivior is expanding into medicines for cannabis-related disorders.
The London-listed company has agreed an upfront $30m rights deal with French biotechnology firm Aelis...